BEAM
Price
$17.41
Change
+$0.16 (+0.93%)
Updated
May 9 closing price
Capitalization
1.75B
93 days until earnings call
HLVX
Price
$1.90
Change
-$0.01 (-0.52%)
Updated
May 9 closing price
Capitalization
95.27M
88 days until earnings call
Ad is loading...

BEAM vs HLVX

Header iconBEAM vs HLVX Comparison
Open Charts BEAM vs HLVXBanner chart's image
Beam Therapeutics
Price$17.41
Change+$0.16 (+0.93%)
Volume$2.38M
Capitalization1.75B
HilleVax
Price$1.90
Change-$0.01 (-0.52%)
Volume$159.6K
Capitalization95.27M
BEAM vs HLVX Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. HLVX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and HLVX is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (BEAM: $17.41 vs. HLVX: $1.90)
Brand notoriety: BEAM and HLVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 90% vs. HLVX: 65%
Market capitalization -- BEAM: $1.75B vs. HLVX: $95.27M
BEAM [@Biotechnology] is valued at $1.75B. HLVX’s [@Biotechnology] market capitalization is $95.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileHLVX’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • HLVX’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and HLVX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while HLVX’s TA Score has 6 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • HLVX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, HLVX is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -13.98% price change this week, while HLVX (@Biotechnology) price change was -3.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

HLVX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.75B) has a higher market cap than HLVX($95.3M). HLVX YTD gains are higher at: -8.213 vs. BEAM (-29.798). HLVX has higher annual earnings (EBITDA): -143.17M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. HLVX (189M). HLVX has less debt than BEAM: HLVX (25M) vs BEAM (161M). BEAM has higher revenues than HLVX: BEAM (63.5M) vs HLVX (0).
BEAMHLVXBEAM / HLVX
Capitalization1.75B95.3M1,837%
EBITDA-383.98M-143.17M268%
Gain YTD-29.798-8.213363%
P/E RatioN/AN/A-
Revenue63.5M0-
Total Cash851M189M450%
Total Debt161M25M644%
TECHNICAL ANALYSIS
Technical Analysis
BEAMHLVX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GLNAX23.110.04
+0.17%
MFS Global New Discovery A
CBFAX37.660.06
+0.16%
American Funds Global Balanced 529A
APDLX14.500.01
+0.07%
Artisan Value Advisor
NDVVX16.96-0.01
-0.06%
MFS New Discovery Value R6
ETHSX12.52-0.10
-0.79%
Eaton Vance Worldwide Health Sci A

HLVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLVX has been closely correlated with FBIOP. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if HLVX jumps, then FBIOP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLVX
1D Price
Change %
HLVX100%
-0.52%
FBIOP - HLVX
83%
Closely correlated
+3.25%
BRIBF - HLVX
55%
Loosely correlated
N/A
PLRX - HLVX
37%
Loosely correlated
-1.40%
NTLA - HLVX
37%
Loosely correlated
-1.93%
SCPH - HLVX
33%
Loosely correlated
-2.79%
More